LP-184

LP-184 · Lantern Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LP-184, covering 2025-03-06 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of LP-184 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]